Sort
51,593 grants matching “hepatitis”
Immunogenicity to B and T cell vaccines in non-human primates (NHPs)
$421,624Bali Pulendran · Stanford University · U19 · FY2022 · AI
Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)
$421,554David A Geller · University Of Pittsburgh At Pittsburgh · R24 · FY2025 · DK
Understanding fatty liver disease using the zebrafish mutant, foie gras
$421,526Kirsten C Sadler Edepli · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AA
Neuromedical Core
$421,506Igor Grant · University Of California, San Diego · P30 · FY2008 · MH
Molecular engineering of factor VIII gene for rAAV delivery
$421,500Weidong Xiao · Temple Univ Of The Commonwealth · R01 · FY2011 · HL
Hepatic Tissue Engineering
$421,496Massachusetts General Hospital · R01 · FY2002 · DK
A Role for the Novel HAF-NFkappaB Axis in Driving Obesity-Associated Liver Cancer
$421,432Mei Yee Koh · University Of Utah · R01 · FY2023 · CA
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and
$421,420Chunqi Li · Phylonix Pharmaceuticals, Inc. · R44 · FY2008 · ES
Developmental Core
$421,401John D Hamilton · Duke University · P30 · FY2012 · AI
Training Program in Substance Use, HIV and Related Infections
$421,383Steffanie A Strathdee · University Of California, San Diego · T32 · FY2018 · DA
Genetic Determinants of Weight Loss and Resolution of Co-Morbidities
$421,278Glenn S Gerhard · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · DK
Occludin-specific HCV cell entry mechanisms
$421,258Matthew J Evans · Icahn School Of Medicine At Mount Sinai · R56 · FY2011 · AI
Role of HCV p7 and NS2 in infectious virus production
$421,250Charles M. Rice · Rockefeller University · R01 · FY2009 · AI
ONTOGENY OF HEPATIC ION TRANSPORT
$421,248Mount Sinai School Of Medicine Of Nyu · R37 · FY2001 · HD
NOVEL THERAPY FOR DIABETES
$421,220Lawrence Chan · Baylor College Of Medicine · R01 · FY2008 · DK
Decoding P. aeruginosa RIP cascade and discovering its inhibitors as therapeutics
$421,190Kalai Mathee · Florida International University · R15 · FY2015 · AI
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
$421,175Lisa B Vanwagner · Ut Southwestern Medical Center · R01 · FY2023 · AA
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort
$421,173Shehnaz Khursheed Hussain · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
$421,077Matthew A Burchill · University Of Colorado Denver · R01 · FY2023 · DK
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
$421,077Matthew A Burchill · University Of Colorado Denver · R01 · FY2020 · DK
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
$421,077Matthew A Burchill · University Of Colorado Denver · R01 · FY2021 · DK
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
$421,077Matthew A Burchill · University Of Colorado Denver · R01 · FY2022 · DK
Inhalable amphotericin B nanodisk therapy for aspergillosis in HIV-infected patie
$421,057Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2007 · AI
Small Regulatory RNAs of Coxiella burnetii - The Agent of Q Fever
$421,034James Michael Battisti · University Of Montana · R15 · FY2013 · AI
PGC-1 and the Control of Hepatic Gluconeogenesis
$421,024Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2010 · DK